- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01908738
Effectiveness of Paracervical Block Versus Lidocaine Spray During Endometrial Biopsy
Effectiveness of Paracervical Block Versus Lidocaine Spray During Endometrial Biopsy Under Oral Analgesic Drugs; A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants : This study was conducted prospectively at the outpatient clinic, Department of Obstetrics and Gynecology, Songklanagarind Hospital.
Inclusion criteria : The women who had abnormal uterine bleeding and indication for endometrial biopsy were enrolled.
Exclusion criteria : included 1) contraindications to NSAID or Lidocaine - known sensitivity to these drugs; 2) pregnancy; 3) genital tract infection; 4) coagulation disorder; and 5) unstable vital signs.
Sample size calculation : Sample size was calculated by assuming the different mean pain score of each groups performing the endometrial biopsy to be 1. To evidence this difference with a power of 80% and a 5% level of significance, a need was calculated with 36 women in each group and for total was 108 women.
Z α/2 = Type I error(alpha error) α = 0.05 >> 1.96 Z β = Type II error(beta error) β = 0.2 >> 0.84
- Variance of mean pain score between procedure and post procedure 15 minutes = 1.5 µ0 = Mean pain score in group 1 µ1 = Mean pain score in group 2 µ0 - µ1 = Different of mean pain score in between each groups = 1 **N = 2(1.5)2(1.96 + 0.84)2/(1)2 = 35.3 N = 36 per group
Study procedures :
- Explain the steps of the procedure to the patient and counseling regarding rational and risks/benefits. Obtain consent for the procedure. Perform bimanual exam to determine uterine size and position.
After signing a written informed consent, the women were randomly allocated to 3 groups. All women will receive Acetaminophen 500 mg and Ibuprofen 400 mg before procedure 30 minutes.
The first groups receive paracervical block with 1%lidocaine and 0.9%NSS spray(placebo), the second groups receive 10%lidocaine spray and paracervical block with 0.9%NSS(placebo) and the third groups receive placebo both paracervical block and spray. Both women and researcher associate were blinded to group allocation. The 1%lidocaine, 10%lidocaine spray and both placebos were prepared in sequentially numbered sealed opaque envelops according to the table of random numbers by an independent pharmacist.
- The time that start oral medication and vital signs before starting procedure were recorded.
- Starting procedure by using largest appropriate speculum for maximum cervical exposure. Cleanse the cervix with povidone iodine. Then administer paracervical block by using local anesthetic drug 5 ml. injects at cervical area 3 and 9 O'clock, depth 0.5-1 cm., 2.5 ml. each sides. After that use anesthetic spray sprays at cervix for 1 times and wait for 3 minutes.
- Endometrial biopsy was performed by using a 3-mm EndosamplerTM (MedGyn EndosamplerTM, MedGyn Product Inc, IL, USA). If insertion of EndosamplerTM failed, a tenaculum was applied to the anterior cervix to help for stabilization and counter-traction.
- After get the endometrial tissue sample, remove all equipments, checked and stopped bleeding. And record vital signs after finish the procedure.
- The form contained a visual analog scale for women to report their responses of pain at immediately after procedure and after that 15 minutes by using Numerical Rating Scale(NRS) were recorded.
- The women were assessed for adverse side effects or complications of procedure e.g. such as dizziness, nausea, vomiting, pelvic pain or others.
- Follow up appointment the women for pathological report result at PSU hospital and consider further management.
Expected outcomes :
To determine effectiveness of paracervical block, lidocaine spray and only oral analgesic drugs for pain relief during endometrial biopsy.
Table. Pain score(NRS) immediately after procedure and 15 minutes Group 1(1%Lidocaine) Group 2(10%Lidocaine spray) Control group(Placebo) Pain score immediately Pain score 15 minutes A secondary goal of this study was to determine the adverse effects of these methods(such as dizziness, nausea, vomiting, pelvic pain, bleeding).
Data analysis :
Data are presented as median (range) for quantitative variables and frequency for qualitative variables. Comparison between both groups was made by using the Chi-square test, Fisher's exact test and Mann-Whitney U test where appropriate with p<0.05 considered statistically significant. Statistical analysis was performed with the SPSS 17.0 package program (Statistical Package for Social Science; SPSS Inc., Chicago, IL, USA).
Ethical consideration :
- Inform consent will be obtained before study procedure.
- The study will not detrimental patients or treatment outcomes.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hatyai
-
Songkla, Hatyai, Thailand, 90110
- Akarawit Jitchanwichai
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- abnormal uterine bleeding women
- indicated for endometrial biopsy
Exclusion Criteria:
- contraindications to NSAID or Lidocaine - known sensitivity to these drugs
- pregnancy
- genital tract infection
- coagulation disorder
- unstable vital signs.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: paracervical block with 1%lidocaine and 0.9%NSS spray(placebo)
first groups receive paracervical block with 1%lidocaine and 0.9%NSS spray(placebo)
|
To determine effectiveness of paracervical block, lidocaine spray and only oral analgesic drugs for pain relief during endometrial biopsy. Pain score(NRS) immediately after procedure and 15 minutes Group 1(1%Lidocaine) Group 2(10%Lidocaine spray) Control group(Placebo) Pain score immediately Pain score 15 minutes |
Experimental: 10%lidocaine spray and paracervical block with 0.9%NSS
the second groups receive 10%lidocaine spray and paracervical block with 0.9%NSS(placebo)
|
|
Placebo Comparator: receive placebo both paracervical block and spray
the third groups receive placebo both paracervical block and spray
|
To determine effectiveness of paracervical block, lidocaine spray and only oral analgesic drugs for pain relief during endometrial biopsy. Pain score(NRS) immediately after procedure and 15 minutes Group 1(1%Lidocaine) Group 2(10%Lidocaine spray) Control group(Placebo) Pain score immediately Pain score 15 minutes |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effectiveness of paracervical block VS Lidocaine spray during endometrial biopsy ; A randomized controlled trial
Time Frame: up to 12 months
|
measurement outcome by record Pain score(NRS)[Numberical rating scale 0-10] immediately after procedure and 15 minutes after procedure in all groups Group 1(1%Lidocaine) Group 2(10%Lidocaine spray) Group 3 Control group(Placebo) Pain score immediately and Pain score 15 minutes were compared between group by using statistic analysis to indentify the significant of decreasing Pain score for pain relief during endometrial biopsy. And after that the result will used to determine effectiveness of each groups[ paracervical block, lidocaine spray and only oral analgesic drugs. |
up to 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
adverse effects of paracervical block versus lidocaine spray
Time Frame: up to 12 months
|
A secondary goal of this study was to determine the adverse effects of these methods(such as dizziness, nausea, vomiting, pelvic pain, bleeding) by recording the adverse effects outcome of each groups and report the result.
|
up to 12 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Uterine Diseases
- Hemorrhage
- Uterine Hemorrhage
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Lidocaine
Other Study ID Numbers
- 56-244-12-4-2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abnormal Uterine Bleeding
-
Women and Infants Hospital of Rhode IslandActive, not recruitingAbnormal Uterine Bleeding | Abnormal Uterine Bleeding, Ovulatory Dysfunction | Abnormal Uterine Bleeding, Endometrial Hemostatic DysfunctionUnited States
-
University of California, DavisWashington University School of MedicineTerminatedUterine Bleeding Heavy | Abnormal Uterine Bleeding, UnspecifiedUnited States
-
Sisli Hamidiye Etfal Training and Research HospitalCompletedAbnormal Uterine Bleeding
-
Chulalongkorn UniversityUnknown
-
Indiana UniversityCompleted
-
Ain Shams UniversityCompletedCesarean Section; Dehiscence | Abnormal Uterine Bleeding
-
Maxima Medical CenterUtrecht UniversityActive, not recruiting
-
The Cleveland ClinicCompletedAbnormal Uterine BleedingUnited States
-
Mahmoud Ramadan HafezRecruitingCesarean Section Niche and Abnormal Uterine BleedingEgypt
-
University of Texas Southwestern Medical CenterWithdrawnAdenomyosis | Abnormal Uterine Bleeding
Clinical Trials on paracervical block with 1%lidocaine
-
University of HawaiiCompleted
-
Children's Hospital of PhiladelphiaUniversity of Pennsylvania; BayerCompleted
-
University of California, San DiegoUniversity of California, Los Angeles; Society of Family PlanningCompletedAbortion in First Trimester | Abortion, Spontaneous | Abortion, Missed | Abortion Early | Pain UterusUnited States
-
Oregon Health and Science UniversityPlanned Parenthood Federation of AmericaCompletedPain | Legal Abortion With ComplicationUnited States
-
University of California, San DiegoCompletedPain Due to Intrauterine Contraceptive DeviceUnited States
-
Kayseri Education and Research HospitalCompleted
-
Maastricht UniversityUnknownDiabetes Mellitus | PolyneuropathiesNetherlands
-
Stanford UniversityCompletedPain Management, Cervical PreparationUnited States
-
Oregon Health and Science UniversityPlanned Parenthood Federation of AmericaCompleted